Adaptation and evaluation of an intersectional stigma reduction intervention to increase HIV care engagement among women who use drugs - This project addresses a pressing American health priority: developing effective strategies to help people living with HIV stay engaged in treatment when they also face stigma related to HIV and drug use. Stigma — the shame and discrimination people experience because of their HIV status or substance use — is one of the most significant barriers to HIV care in the United States today. Americans living with HIV, particularly women and people with substance use disorders, face these overlapping stigmas daily, contributing to missed medications, dropped care, and ultimately worse health outcomes. Yet few interventions have been designed and rigorously tested to address both stigmas at once. This project will develop and pilot-test such an intervention, then generate findings directly applicable to U.S. HIV care programs and clinical practice. The research is conducted in Ukraine because Ukraine offers a scientifically unique and efficient setting for this work that is not available in the United States: it has one of Europe’s most concentrated HIV epidemics, a high burden of injection drug use, and a population of women living with HIV who use drugs that is substantially larger than comparable U.S. populations. This makes it possible to recruit, enroll, and study a sufficient number of participants to rigorously test the intervention in a way that would take far longer and cost far more in a U.S. setting. Ukraine also has a highly experienced research team and established research infrastructure with a strong track record working with this population, ensuring high-quality data and efficient use of NIH resources. Moreover, the Ukrainian Institute of Public Health Policy (UIPHP) has extensive experience testing interventions (e.g., MARTAS/Modified ARTAS and HPTN 074), with evidence from these efforts informing effective practices later used in the United States, thereby enhancing the feasibility, rigor, and translational potential of the proposed study. The scientific insights gained — about which intervention components reduce stigma, improve medication adherence, and increase retention in care — are directly transferable to American communities where HIV and substance use intersect. We will adapt the evidence-informed “Workshop” intervention, a small-group, multi-session program designed to reduce internalized and anticipated stigma, strengthen coping and communication skills, increase social support, and address structural barriers to HIV treatment and substance use services. This pilot study will increase understanding of the intervention and contextual factors that will facilitate a larger RCT to determine the effectiveness of the intervention for HIV+ WWUD. Importantly, the study will generate evidence directly relevant to U.S. efforts to improve HIV retention in care, reduce disparities through a solution-oriented approach, strengthen integration of HIV and addiction services, and identify factors that improve the uptake of and access to existing medical and behavioral interventions that can significantly limit and eventually eradicate HIV infection from the United States.